Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-22-000036

CFO and Treasurer sold 1,296 shares at $37.09 ($48,073)

From the SEC's structured data for this filing

Trades in this filing

Krognes Steve E. · CFO and Treasurer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-02-09 Sale : show line 1 in the form −1,296 $37.09 $48,073 122,781 D
Open-market sales · 1,296 sh · avg $37.09 · $48,073
Loading xslF345X03/wf-form4_164461802552345.xml…